ABL Bio Inc (298380) — Cash Flow Reinvestment Rate
ABL Bio Inc (298380) has a Cash Flow Reinvestment Rate of 2.31x as of June 2025, reinvesting ₩88.52 Billion (capex ₩8.47 Billion plus investments ₩80.05 Billion) from operating cash flow of ₩38.30 Billion. Explore ABL Bio Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ABL Bio Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for ABL Bio Inc across 1 annual periods. Also explore ABL Bio Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ABL Bio Inc (2022–2022)
Year-by-year capital reinvestment analysis for ABL Bio Inc. For live market cap and broader valuation context, see ABL Bio Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.67x | ₩48.29 Billion | ₩72.13 Billion | ₩2.06 Billion | — |